FDA Import Refusal 112-0417961-3/1/2 — Novartis Healthcare

Novartis Healthcare — FEI 3001727058

The FDA refused shipment 112-0417961-3/1/2 from Novartis Healthcare (Philippines) on Mar 8, 2011. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charges: 118,75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Mar 8, 2011
Country
Philippines
Product Category
Drugs and Biologics
Product Code
62OCA14 AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
Charges
118,75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.